|
Market Cap (3-Jul) $61,961,900 (532nd) |
Close (30-Jun) $0.78 |
Volume (30-Jun) 230,813 |
Shortsold (19-Jun) 25,352 (0.02%) (510th) |
|
52w High $0.94 |
52w Low $0.385 |
P/E 166.67 |
EPS -0.34 |
MVP released this announcement to the ASX on 6 February 2023, 15:16. The announcement is not marked as price sensitive, and is 1 page(s) in length and 94.19kb in size.
You can view all announcements from MVP and see how they appear on a price chart on the announcements page.
At the date of this announcement, MVP was 0.215% short sold according to ASIC data. It was ranked the 403rd most shorted stock on the ASX. It remains ranked 510th as of the latest reported data (19 June 2025).
| Other Recent Announcements from MVP | |
|---|---|
| Change in substantial holding | 15 May 2023, 16:59 |
| Final Director's Interest Notice - D. Williams | 26 April 2023, 14:29 |
| Resignation of Director | 18 April 2023, 9:18 |
| Half Year Results Announcement Details | 6 February 2023, 15:16 |
| Notification of cessation of securities - MVP | 20 January 2023, 12:50 |
| Notification regarding unquoted securities - MVP | 20 January 2023, 12:48 |
| China Clinical Trials Discontinued | 18 January 2023, 9:06 |
You must be logged in to post a reply.
Medical Developments International 